Day of Reckoning for Boston’s Lab Market
Greater Boston’s lab real estate boom has shifted to a glut, with brokers and lenders citing high vacancy and limited lab tenant demand. Alexandria Real Estate Equities is pursuing non-life-science uses, while Onto Innovation leased 160,000 sq ft at $17/sf. CBRE tracks 2.45M sq ft of lab demand vs 16.6M vacant. Mass General Brigham is reportedly taking space at 74M. BXP expects AI and office users to absorb some inventory; lenders may force more distressed sales.



